The Soy-derived Peptide Vglycin Inhibits the Growth of Colon Cancer Cells In vitro and In vivo

Overview

Journal Exp Biol Med (Maywood)

Specialty Biology

Date 2017 May 12

PMID 28492347

Citations 4

Authors

Chang Gao

Rui Sun

Ya-Rong Xie

An-Li Jiang

Mei Lin

Min Li

Zheng-Wang Chen

Ping Zhang

Honglin Jin

Jue-Ping Feng

Affiliations

Soon will be listed here.

Abstract

Vglycin, a novel natural polypeptide isolated from pea seeds, possesses antidiabetic properties. Our previous studies have shown that Vglycin can induce the differentiation of human colon adenocarcinoma cells. We aimed to determine the anticancer activity of Vglycin against colon cancer cells and to elucidate related apoptosis-inducing mechanisms. Treatment with purified Vglycin significantly reduced growth, viability, and colony formation of CT-26, SW480, and NCL-H716 colon cancer cells in a dose-dependent manner while down-regulating the expression of proliferating cell nuclear antigen. Mouse xenograft studies showed a 38% inhibition of colon cancer growth in mice treated with Vglycin (20 mg/kg/day) at day 21. Furthermore, the potential mechanisms involved in Vglycin-induced cell apoptosis were examined using cell cycle studies, ultrastructural examination, as well as apoptosis-associated pathway analysis. The results showed that Vglycin significantly promoted apoptosis and G1/S phase cell cycle arrest. As revealed by Western blot, the expression of CDK2 and Cyclin D1 was down-regulated in all three Vglycin-treated colon cancer cells, indicating that the CDK2/Cyclin D1 cell cycle pathway involved in the initiation and progression of colon cancer. Moreover, the inhibition of Vglycin-induced cell proliferation in colon cancer cells was accompanied by alteration of the expression levels of the apoptosis-related proteins Bax, Bcl-2 and Mcl-1, and an increase of caspase-3 activity. Together, our results suggest that Vglycin may be another plant-derived peptide that suppresses colon cancer, supporting the continued investigation of Vglycin as therapeutic agent for colon cancer. Impact statement The antidiabetic properties and the capability of inducing differentiation of human colon adenocarcinoma cells of Vglycin have been reported in our previous studies. However, the anticancer potential of Vglycin on colon cancer cells and its possible related mechanisms were still unknown. In this study, we found that Vglycin could reduce growth, viability, and colony formation or colony size of CT-26, SW480, and NCL-H716 colon cancer cells. Moreover, Vglycin decreased tumor volume by 38% in xenograft mice transplanted with CT-26 cells. The mechanisms of these phenomena may be due to the down-regulated CDK2 and Cyclin D1, G1/S phase cell cycle arrest, and the dysregulated expression of Bax, Bcl-2, and Mcl-1. The findings highlight the anticancer potential of Vglycin against colon cancer cells, and suggest Vglycin may be another colon cancer potential suppressive component of plant-derived peptides.

Citing Articles

Natural Peptides Inducing Cancer Cell Death: Mechanisms and Properties of Specific Candidates for Cancer Therapeutics.

Trinidad-Calderon P, Varela-Chinchilla C, Garcia-Lara S Molecules. 2021; 26(24).

PMID: 34946535 PMC: 8708364. DOI: 10.3390/molecules26247453.

Protein Hydrolysates from Fenugreek () as Nutraceutical Molecules in Colon Cancer Treatment.

Allaoui A, Gascon S, Benomar S, Quero J, Osada J, Nasri M Nutrients. 2019; 11(4).

PMID: 30925798 PMC: 6521099. DOI: 10.3390/nu11040724.

Melittin Induced G1 Cell Cycle Arrest and Apoptosis in Chago-K1 Human Bronchogenic Carcinoma Cells and Inhibited the Differentiation of THP-1 Cells into Tumour- Associated Macrophages.

Tipgomut C, Wongprommoon A, Takeo E, Ittiudomrak T, Puthong S, Chanchao C Asian Pac J Cancer Prev. 2018; 19(12):3427-3434.

PMID: 30583665 PMC: 6428562. DOI: 10.31557/APJCP.2018.19.12.3427.

The effect of the type of dietary protein on the development of ovarian cancer.

Taha A, Koshiyama M, Matsumura N, Abiko K, Yamaguchi K, Hamanishi J Oncotarget. 2018; 9(35):23987-23999.

PMID: 29844867 PMC: 5963616. DOI: 10.18632/oncotarget.25253.

References

Benzeno S, Narla G, Allina J, Cheng G, Reeves H, Banck M . Cyclin-dependent kinase inhibition by the KLF6 tumor suppressor protein through interaction with cyclin D1. Cancer Res. 2004; 64(11):3885-91. DOI: 10.1158/0008-5472.CAN-03-2818. View

Perciavalle R, Opferman J . Delving deeper: MCL-1's contributions to normal and cancer biology. Trends Cell Biol. 2012; 23(1):22-9. PMC: 3532576. DOI: 10.1016/j.tcb.2012.08.011. View

Flanagan L, Meyer M, Fay J, Curry S, Bacon O, Duessmann H . Low levels of Caspase-3 predict favourable response to 5FU-based chemotherapy in advanced colorectal cancer: Caspase-3 inhibition as a therapeutic approach. Cell Death Dis. 2016; 7:e2087. PMC: 4849164. DOI: 10.1038/cddis.2016.7. View

Wang T, Cardiff R, Zukerberg L, Lees E, Arnold A, SCHMIDT E . Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature. 1994; 369(6482):669-71. DOI: 10.1038/369669a0. View

He X, Xiang H, Zong X, Yan X, Yu Y, Liu G . CDK2-AP1 inhibits growth of breast cancer cells by regulating cell cycle and increasing docetaxel sensitivity in vivo and in vitro. Cancer Cell Int. 2015; 14(1):130. PMC: 4279590. DOI: 10.1186/s12935-014-0130-8. View

Thornberry N, Lazebnik Y . Caspases: enemies within. Science. 1998; 281(5381):1312-6. DOI: 10.1126/science.281.5381.1312. View

Ortiz-Martinez M, Winkler R, Garcia-Lara S . Preventive and therapeutic potential of peptides from cereals against cancer. J Proteomics. 2014; 111:165-83. DOI: 10.1016/j.jprot.2014.03.044. View

Dutta S, Ryan J, Chen T, Kougentakis C, Letai A, Keating A . Potent and specific peptide inhibitors of human pro-survival protein Bcl-xL. J Mol Biol. 2014; 427(6 Pt B):1241-1253. PMC: 4357494. DOI: 10.1016/j.jmb.2014.09.030. View

Gonzalez de Mejia E, Bradford T, Hasler C . The anticarcinogenic potential of soybean lectin and lunasin. Nutr Rev. 2003; 61(7):239-46. DOI: 10.1301/nr.2003.jul.239-246. View

10.

Zorofchian Moghadamtousi S, Rouhollahi E, Karimian H, Fadaeinasab M, Firoozinia M, Abdulla M . The chemopotential effect of Annona muricata leaves against azoxymethane-induced colonic aberrant crypt foci in rats and the apoptotic effect of Acetogenin Annomuricin E in HT-29 cells: a bioassay-guided approach. PLoS One. 2015; 10(4):e0122288. PMC: 4393181. DOI: 10.1371/journal.pone.0122288. View

11.

Ho C, Hu F, Lee S, Shieh T, Yu C, Lin S . ZEB1 as an indicator of tumor recurrence for areca quid chewing-associated oral squamous cell carcinomas. J Oral Pathol Med. 2014; 44(9):693-8. DOI: 10.1111/jop.12286. View

12.

Zou Y, Chang S . Effect of black soybean extract on the suppression of the proliferation of human AGS gastric cancer cells via the induction of apoptosis. J Agric Food Chem. 2011; 59(9):4597-605. DOI: 10.1021/jf104945x. View

13.

Chan C, Supriady H, Goh B, Kadir H . Elephantopus scaber induces apoptosis through ROS-dependent mitochondrial signaling pathway in HCT116 human colorectal carcinoma cells. J Ethnopharmacol. 2015; 168:291-304. DOI: 10.1016/j.jep.2015.03.072. View

14.

Nehls O, Okech T, Hsieh C, Enzinger T, Sarbia M, Borchard F . Studies on p53, BAX and Bcl-2 protein expression and microsatellite instability in stage III (UICC) colon cancer treated by adjuvant chemotherapy: major prognostic impact of proapoptotic BAX. Br J Cancer. 2007; 96(9):1409-18. PMC: 2360187. DOI: 10.1038/sj.bjc.6603728. View

15.

Broecker-Preuss M, Viehof J, Jastrow H, Becher-Boveleth N, Fuhrer D, Mann K . Cell death induction by the BH3 mimetic GX15-070 in thyroid carcinoma cells. J Exp Clin Cancer Res. 2015; 34:69. PMC: 4510903. DOI: 10.1186/s13046-015-0186-x. View

16.

Hsieh C, Hernandez-Ledesma B, Jeong H, Park J, de Lumen B . Complementary roles in cancer prevention: protease inhibitor makes the cancer preventive peptide lunasin bioavailable. PLoS One. 2010; 5(1):e8890. PMC: 2811193. DOI: 10.1371/journal.pone.0008890. View

17.

Vermeulen K, Bockstaele D, Berneman Z . The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif. 2003; 36(3):131-49. PMC: 6496723. DOI: 10.1046/j.1365-2184.2003.00266.x. View

18.

Danial N . BCL-2 family proteins: critical checkpoints of apoptotic cell death. Clin Cancer Res. 2007; 13(24):7254-63. DOI: 10.1158/1078-0432.CCR-07-1598. View

19.

Billard C . BH3 mimetics: status of the field and new developments. Mol Cancer Ther. 2013; 12(9):1691-700. DOI: 10.1158/1535-7163.MCT-13-0058. View

20.

Jiang H, Feng J, Du Z, Zhen H, Lin M, Jia S . Oral administration of soybean peptide Vglycin normalizes fasting glucose and restores impaired pancreatic function in Type 2 diabetic Wistar rats. J Nutr Biochem. 2014; 25(9):954-63. DOI: 10.1016/j.jnutbio.2014.04.010. View